Management of scleral melt.
Scleral enforcement
Scleral graft
Scleral melt
Scleral necrosis
Journal
The ocular surface
ISSN: 1937-5913
Titre abrégé: Ocul Surf
Pays: United States
ID NLM: 101156063
Informations de publication
Date de publication:
01 2023
01 2023
Historique:
received:
24
07
2022
revised:
14
12
2022
accepted:
17
12
2022
pubmed:
23
12
2022
medline:
18
1
2023
entrez:
22
12
2022
Statut:
ppublish
Résumé
Scleral melting, while rare, can lead to significant ocular morbidity. Several possible risk factors for scleral melt have been identified, such as infection, autoimmune disease, trauma, and post-surgical state, and these may act in combination with each other. Treatment should be tailored according to the etiology and severity of the scleral melt. Medical management may be indicated, especially in cases of autoimmune-related melt; however, surgical procedures are often necessary due to compromised ocular integrity and limited penetration of medications into the avascular sclera. An understanding of the surgical options available and their operative outcomes is particularly important when choosing the appropriate treatment protocol for each patient.
Identifiants
pubmed: 36549583
pii: S1542-0124(22)00122-7
doi: 10.1016/j.jtos.2022.12.005
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
92-99Informations de copyright
Copyright © 2022 Elsevier Inc. All rights reserved.